In a study published recently in the journal Clinical Cancer Research, researchers at Baylor College of Medicine found that treating patients who have resectable malignant pleural mesothelioma, meaning that their tumor can ...
Dec 13, 2022
0
5
More than half of all patients who receive solid organ transplants will have an incidence of skin cancer at some point—most often a nonmelanoma cancer, such as basal cell carcinoma or squamous cell carcinoma. This increased ...
Dec 6, 2022
0
10
Immune checkpoint inhibitors activate the body's immune system against tumors. Although this cancer treatment has shown remarkable success, the patient's chance of responding to the treatment remains unpredictable. Scientists ...
Dec 5, 2022
0
36
In many cancer types, cancer cells try to survive by escaping attack from the immune system. These cancer cells hijack mechanisms called immune checkpoints to trick the immune system into thinking they are healthy cells. ...
Nov 28, 2022
0
82
Duke Cancer Institute researchers have identified potential biomarkers that predict the likelihood for checkpoint inhibitor drugs to backfire, driving hyper-progression of melanoma cells instead of unleashing the immune system ...
Nov 23, 2022
0
64
A single drug compound simultaneously attacks hard-to-treat prostate cancer on several fronts, according to a new study in mice and human cells. It triggers immune cells to attack, helps the immune cells penetrate the tumor, ...
Nov 23, 2022
0
76
Immune checkpoint inhibitors such as Keytruda and Opdivo work by unleashing the immune system's T cells to attack tumor cells. Their introduction a decade ago marked a major advance in cancer therapy, but only 10% to 30% ...
Nov 15, 2022
0
29
Cancer cells use sugar molecules on their surfaces to disable attacks by the body's immune system. Researchers at the University of Basel now report on how this mechanism can be neutralized.
Nov 7, 2022
0
726
A Rochester Institute of Technology scientist helped develop a new mathematical model that could aid doctors and patients assessing different approaches for treating metastatic cancer. Assistant Professor Nourridine Siewe ...
Nov 4, 2022
0
2
Duke Health researchers have identified a unique process within the environment of deadly brain tumors that drives resistance to immune-boosting therapies and could be targeted to promote the effects of those drugs.
Nov 3, 2022
0
41
